Open access
3,481
Views
12
CrossRef citations to date
0
Altmetric
Review
Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems
A Saint-Raymonda International Affairs Division, European Medicines Agency, Amsterdam, EUCorrespondence[email protected]
, J Satob Office of International Programs, Pharmaceutical and Medical Devices Agency, Tokyo, Japan
, Y Kishiokab Office of International Programs, Pharmaceutical and Medical Devices Agency, Tokyo, Japan
, T Teixeiraa International Affairs Division, European Medicines Agency, Amsterdam, EU
, C Hasslboecka International Affairs Division, European Medicines Agency, Amsterdam, EU
& SL Kwederc European Office, Office of International Programs, Food and Drug Administration, Silver Spring, MD, USA
Pages 1095-1101
|
Received 05 Jul 2020, Accepted 07 Sep 2020, Published online: 29 Sep 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.